share_log

Citigroup Maintains Buy on Cabaletta Bio, Raises Price Target to $30

Moomoo 24/7 ·  Apr 4 11:47

Citigroup analyst Samantha Semenkow maintains Cabaletta Bio (NASDAQ:CABA) with a Buy and raises the price target from $26 to $30.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment